Problematic polypharmacy: prescribing cascades evidence evaluation – GNPRC 2022

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2022.

The identification and reversal of prescribing cascades represents an important and underappreciated opportunity to reduce inappropriate medication use and preventable ADRs, and to make prescribing more environmentally sustainable The overall purpose of this evidence evaluation is to raise awareness of potential prescribing cascades and to highlight strategies, tools, and resources to help identify, prevent, and resolve them.

Download the poster here.

An abstract is also available.

Quantification of respiratory inhaler carbon footprint in primary care prescribing – GNPRC 2022

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2022. It aims to assign a carbon footprint for all respiratory inhalers and refills, and provide this information alongside the primary care prescribing costs for all RDTC stakeholder CCGs in the form of a calculator.

Download the poster here.

An abstract is also available.

Electronic Repeat Dispensing – GNPRC 2022

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2022. It aims to highlight the benefits of electronic repeat dispensing (eRD) and examine its use at Integrated Care System level in the North of England, to support systems in identifying where prescribing processes may be further streamlined.

Download the poster here.

An abstract is also available.

Carbon footprint of anaesthetic gases across NENC ICS – GNPRC 2022

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2022. It calculates the carbon footprint of anaesthetic gases used in both primary and secondary care in NENC, in order to determine an ICS-level carbon footprint.

Download the poster here.

An abstract is also available.

Formulary assessment – melatonin (Adaflex) for ADHD

Formulary assessment tools are templates to support local decision making. They list NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies.

The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The purpose of the document is to support consistent decision making by formulary groups and APCs.

This information is produced for use by NHS healthcare professionals and RDTC stakeholders.

Monthly Horizon Scanning Report – July 2022

Monthly horizon scanning reports are designed to inform the NHS about new products, significant changes to product licenses, significant new guidance, and decisions that have been made by recognised bodies. 

This information is produced for use by NHS healthcare professionals. 

Prescribing Update Newsletter – July 2021

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s newsletter covers our new website, the latest healthcare professional letter on sodium valproate, and an update on the use of chloramphenicol eyedrops in children. It also continues a series of spotlight articles on our prescribing data reports; this month take a look at our Financial Headlines.

Monthly Horizon Scanning Report – July 2021

Monthly horizon scanning reports are designed to inform the NHS about new products, significant changes to product licenses, significant new guidance, and decisions that have been made by recognised bodies

This information is produced for use by NHS healthcare professionals. 

Prescribing Update Newsletter – July 2020

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

Covid-19 impact on prescribing costs bulletin